Delivery Order SPE2DX22D0099-SPE2D826FAA6V
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,353.67 by the Defense Logistics Agency's Medical Supply Chain on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order, which is a non-set-aside award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,011.09 by the Defense Logistics Agency's Medical Supply Chain on October 1, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,407.00 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,930.98 on October 13, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is expected to be completed by October 14, 2025, represents a child contract under a larger indefinite delivery contract (IDC) vehicle. The award was competitively procured with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,994.94 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed price delivery order, which is effective through July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $782,486.45 by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,511.48 by the Defense Logistics Agency's Medical Supply Chain on October 13, 2025. This firm fixed price delivery order, which is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), represents a competitively awarded non-set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $182,754.50 from the Defense Logistics Agency's Medical Supply Chain on September 24, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 25, 2025, represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,964.41 by the Defense Logistics Agency's Medical Supply Chain on October 1, 2025. This firm fixed price delivery order, with an ultimate completion date of October 2, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D826FAA6VDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,750.82 by the Defense Logistics Agency's Medical Supply Chain on October 13, 2025. This firm fixed-price delivery order, which is not set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX and valued at $999,999,999.00 through December 2026. The ultimate completion date for this delivery order is October 14, 2025, with performance taking place at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's critical role as a pharmaceutical prime vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive product portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The SPE2DX prime indefinite vehicle serves as a global pharmaceutical support mechanism enabling AmerisourceBergen to supply medical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 10/13/25 |